Clinical trials - Press Releases

Date	Title	Company
26-Jan-2023	Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast	Almac Group
26-Jan-2023	New spray fights infections and antibiotic resistance	The World Health Organization
26-Jan-2023	Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107	Douglas Pharmaceuticals
26-Jan-2023	ONXEO provides update on the Development Program for its first-in-class drug candidate AsiDNATM	Onxeo
26-Jan-2023	Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease	Orbsen Therapeutics Limited
26-Jan-2023	Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III	Novartis
26-Jan-2023	First CAR T-cell therapy recommended for routine use on the NHS in England	Gilead Sciences Ltd
26-Jan-2023	Blackford and Brainomix Announce AI Partnership for Stroke Care	Blackford
26-Jan-2023	Bloomsbury Genetic Therapies Announces Orphan Drug Designations of BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome	Bloomsbury Genetic Therapies Limited
26-Jan-2023	Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize	University of Calgary
26-Jan-2023	Nutricia pioneers its first plant-based medical nutrition drink	Nutricia
26-Jan-2023	Cancer cells shrink or super-size to survive	The Institute of Cancer Research
25-Jan-2023	Cell Therapy Market is estimated to be US$ 19.6 billion by 2030 with a CAGR of 13.1% during the forecast period	prophecy
20-Jan-2023	The Lancet Neurology publishes results from Minoryx Therapeutics Phase 2/3 ADVANCE clinical trial of leriglitazone in X-linked Adrenoleukodystrophy	Minoryx Therapeutics
19-Jan-2023	Trial and Error - do our clinical trials match the ages of those who need medicines most?	International Longevity Centre (ILC)
19-Jan-2023	Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium	Servier and Taiho Oncology
18-Jan-2023	Clinical trial gives terminal cancer patient new lease of life	The Christie
18-Jan-2023	AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease	AC Immune
18-Jan-2023	Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults	Moderna
18-Jan-2023	Spectral MD (SMD.L*): Interim results from DFU trial shows improvement in DeepView diagnostic accuracy	Spectral MD